AMAG Pharmaceuticals Inc. (AMAG)

13.09
NASDAQ : Health Technology
Prev Close 12.06
Day Low/High 12.09 / 13.45
52 Wk Low/High 6.81 / 23.77
Avg Volume 1.30M
Exchange NASDAQ
Shares Outstanding 33.90M
Market Cap 408.85M
EPS -4.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Image 1: AMAG Share Price Jan 3, 2017 - July 31, 2019 (Graphic: Business Wire)

Image 1: AMAG Share Price Jan 3, 2017 - July 31, 2019 (Graphic: Business Wire)

Caligan Partners LP ("Caligan"), one of the largest shareholders of AMAG Pharmaceuticals, Inc.

AMAG Sends Letter To Shareholders

AMAG Sends Letter To Shareholders

Urges Shareholders Take No Action On Caligan Consent Solicitation

Interesting AMAG Put And Call Options For December 20th

Interesting AMAG Put And Call Options For December 20th

Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading today, for the December 20th expiration.

AMAG Pharmaceuticals Announces Commercial Availability Of Vyleesi™ (Bremelanotide Injection)

AMAG Pharmaceuticals Announces Commercial Availability Of Vyleesi™ (Bremelanotide Injection)

The First FDA-Approved As-Needed Treatment for  Premenopausal Women  Experiencing Low Sexual Desire and Associated Distress Now Available to Patients WALTHAM, Mass.

AMAG Crosses Above Average Analyst Target

AMAG Crosses Above Average Analyst Target

In recent trading, shares of AMAG Pharmaceuticals, Inc. have crossed above the average analyst 12-month target price of $11.78, changing hands for $11.83/share.

The Slowdown Stocks: Cramer's 'Mad Money' Recap (Monday 8/12/19)

The Slowdown Stocks: Cramer's 'Mad Money' Recap (Monday 8/12/19)

On a brutal day in an increasingly shaky market, Jim Cramer looks for companies that can meet the the challenges of China, the Fed, or a slowdown.

AMAG Pharmaceuticals Announces Second Quarter 2019 Financial Results And Provides Corporate Update

AMAG Pharmaceuticals Announces Second Quarter 2019 Financial Results And Provides Corporate Update

Promoted products achieved sequential and year-over-year revenue and market share growth 2019 financial guidance lowered: exiting Makena intramuscular market and removing milestone revenue Vyleesi on-track for national launch in September Conference call...

AMAG Pharmaceuticals To Host Second Quarter 2019 Financial Results Conference Call And Webcast On Wednesday, August 7, 2019 At 8:00 A.m. ET

AMAG Pharmaceuticals To Host Second Quarter 2019 Financial Results Conference Call And Webcast On Wednesday, August 7, 2019 At 8:00 A.m. ET

WALTHAM, Mass., July 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc.

First Week Of September 20th Options Trading For AMAG Pharmaceuticals (AMAG)

First Week Of September 20th Options Trading For AMAG Pharmaceuticals (AMAG)

Investors in AMAG Pharmaceuticals, Inc. saw new options become available this week, for the September 20th expiration.

First Week Of February 2020 Options Trading For AMAG Pharmaceuticals (AMAG)

First Week Of February 2020 Options Trading For AMAG Pharmaceuticals (AMAG)

Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading this week, for the February 2020 expiration.

Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women

Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women

About 6 million women suffer from hypoactive sexual desire disorder, which Palatin's Vyleesi is designed to treat.

AMAG Pharmaceuticals Could Be Cut in Half Even From Here - Avoid

AMAG Pharmaceuticals Could Be Cut in Half Even From Here - Avoid

I was not familiar with the company nor the chart of the stock so it got my attention. Let's check.

Nio, Hexo, Microsoft, Adobe: 'Mad Money' Lightning Round

Nio, Hexo, Microsoft, Adobe: 'Mad Money' Lightning Round

A roundup of Jim Cramer's thoughts on stocks of interest to Mad Money viewers.

Don't Get Complacent: Cramer's 'Mad Money' Recap (Tuesday 6/4/19)

Don't Get Complacent: Cramer's 'Mad Money' Recap (Tuesday 6/4/19)

Key oscillator signal works again, but that's no reason to nod off, Jim Cramer says.

AMAG Pharmaceuticals Enters Oversold Territory (AMAG)

AMAG Pharmaceuticals Enters Oversold Territory (AMAG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of AMAG July 19th Options Trading

First Week Of AMAG July 19th Options Trading

Investors in AMAG Pharmaceuticals, Inc. saw new options become available this week, for the July 19th expiration.

Interesting AMAG Put And Call Options For June 21st

Interesting AMAG Put And Call Options For June 21st

Investors in AMAG Pharmaceuticals, Inc. saw new options become available this week, for the June 21st expiration.

AMAG Pharmaceuticals Is Now Oversold (AMAG)

AMAG Pharmaceuticals Is Now Oversold (AMAG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of November 15th Options Trading For AMAG Pharmaceuticals (AMAG)

First Week Of November 15th Options Trading For AMAG Pharmaceuticals (AMAG)

Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading this week, for the November 15th expiration.

First Week Of August 16th Options Trading For AMAG Pharmaceuticals (AMAG)

First Week Of August 16th Options Trading For AMAG Pharmaceuticals (AMAG)

Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading this week, for the August 16th expiration.

AMAG Pharmaceuticals Becomes Oversold (AMAG)

AMAG Pharmaceuticals Becomes Oversold (AMAG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

AMAG Pharmaceuticals Becomes Oversold (AMAG)

AMAG Pharmaceuticals Becomes Oversold (AMAG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

AMAG Pharmaceuticals Breaks Below 200-Day Moving Average - Notable For AMAG

AMAG Pharmaceuticals Breaks Below 200-Day Moving Average - Notable For AMAG

In trading on Thursday, shares of AMAG Pharmaceuticals, Inc. crossed below their 200 day moving average of $21.15, changing hands as low as $16.91 per share.

AMAG Crosses Above Average Analyst Target

AMAG Crosses Above Average Analyst Target

In recent trading, shares of AMAG Pharmaceuticals, Inc. have crossed above the average analyst 12-month target price of $22.88, changing hands for $23.68/share.

TheStreet Quant Rating: D (Sell)